Printer Friendly

COMPANY INFORMATION
Welichem Biotech Inc. 316-4475 Weyburne Dr Burnaby, BC V5G 3L1 Tel: (604) 432-1703 Fax: (604) 432-1704 Contact Name York Yingping Guo Industry Biotechnology		Key Executives Liren Tang, CEO Jane Zhao Yue, CFO Researches and develops therapeutics for autoimmune/inflammatory diseases and cancer based on novel families of compounds discovered using the SymbioChem® technology.
FP ADVISOR COVERAGE Welichem Biotech Inc. • FP Corporate Surveys • FP Predecessor & Defunct • Ordering FP Products		TOP INDUSTRY PLAYERS Biotechnology Company Name Revenue ($000s)  Atrium Innovations Inc. 309,546 Angiotech Pharmaceuticals, Inc. 302,251 QLT Inc. 132,457 Oncothyreon Inc. 42,678 AEterna Zentaris Inc. 41,056 (Links are to Snapshots.)
FINANCIAL RATIOS AS OF FEB 3/10 Listed Close 52-wk High 52-wk Low IAD Latest Dividend Yield 60-mo Beta TSX-VEN/WBI $0.09 $0.45 $0.09 n.a. n.a. n.a. n.a. Avg 20-day Volume P/E 12-mo EPS EPS Date 1-yr Return 3-yr Return 5-yr Return Market Cap. (000s) 1,525 n.a. $-0.20 Feb. 28/09 -57.5% -56.03% n.a. $3,599
ANNUAL FINANCIALS Periods ended: 12m May 31/08 12m May 31/07 12m May 31/06 $000s $000s $000s Net income (2,520) (3,201) (2,379) Total assets 5,389 1,764 760 $ $ $ Earnings per share* (0.30) (0.50) (0.80) % % % Return on equity (99.55) (361.69) (155.95)   * Common

COMPANY NEWS

Results for 'Welichem Biotech Inc.' from past 30 days: No hits. (Links are to articles.)